Modernizing Medicine today announced it ranked No. 57 on Deloitte’s Technology Fast 500™, a ranking of the 500 fastest growing technology, media, telecommunications, life sciences and energy tech companies in North America. Modernizing Medicine grew 1,494 percent during this period.
Modernizing Medicine’s chief executive officer, Daniel Cane, credits the substantial demand for specialty-specific healthcare technologies with the company’s large revenue growth. Cane said, “It is an incredible honor to be named to Deloitte’s 2015 Technology Fast 500 list. Modernizing Medicine’s accelerated growth serves as a testament to the increased need for specialized technology services in the healthcare sector. We believe the confluence of cloud, mobile and data holds substantial value, and it is our mission to provide a best-of-breed solution capable of capturing that data and utilizing it to help doctors make more informed decisions for their patients. I’m extremely proud of my team and what we have achieved.”
A Jupiter scientist’s ambitious proposal to take on more than 30 incurable illnesses including Lou Gehrig’s Disease has won a prestigious $4.8 million, five-year award announced Tuesday by the National Institutes of Health.
Matthew D. Disney, a professor on the Florida campus of The Scripps Research Institute, has been awarded a 2015 Pioneer Award, one of 13 given this year.
The award is part of the federal agency’s High Risk, High Reward research program, officials said. Disney pitched a plan to defuse devastating illnesses by getting diseased cells to open their doors to chemical con artists that seek out and work only on them.
“Really what we want to do is show this works not just for one disease but many diseases,” Disney told The Palm Beach Post. “This is an immense challenge.”
The idea, as he put it in a statement that formally announced the award, is to “trick disease-affected cells into making their own drug against diseases for which there are no known cures.”
The co-founder of a Boca Raton medical technology startup said Tuesday his company is about to embark on a hiring blitz, adding at least 100 new employees to his 430-person firm.
Daniel Cane, co-founder and CEO of five-year-old Modernizing Medicine, told the South Florida Business Journal that he’s bullish on his firm’s ability to tap into the South Florida tech talent pool, even as others have criticized the availability of human resources locally to fill positions in forward technology companies.
Modernizing Medicine, Inc., the creator of the Electronic Medical Assistant® (EMA™), a cloud-based, specialty-specific electronic medical record (EMR) system, announced today that it has closed a $38 million Series E financing, bringing total capital raised to approximately $87 million.
The investors in the latest round of financing included Pentland Group and funds affiliated with Summit Partners and Sands Capital Ventures.
Brian Garr had his heart set on building the next “killer” medical app for Google Glass. When his cardiologist told him that idea wouldn’t pan out, however, the Boca Raton serial entrepreneur turned to keeping doctors’ revenues from flatlining.
Garr, who’s fresh from selling the technology assets of his prior venture LinguaSys, credits his physician Jean-Pierre Awaida with the idea behind his new company Doc-quick. At a check-up last March, the Delray Beach cardiologist listened to Garr go on about his plan for creating a medical data tool that physicians wearing augmented reality glasses could use. Awaida instead suggested Garr use his 21st-century tools to solve a much older and persistent problem for clinicians – what to do when patients simply don’t show up for appointments.
Palm Beach County‘s life science industry — controversial for the amount of tax dollars sunk into it more than a decade ago — will be put under a microscope for potential expansion.
Business Development Board president Kelly Smallridge on Tuesday unveiled an effort aimed at expanding the county’s life science businesses.
The economic development group is “going back to the table to inventory the county’s life science assets,” Smallridge said.
A $55,000 study by Maryland-based Facility Logix will help the Business Development Board understand the assets of the life science sector and identify gaps to better market the county, she said.
The county’s biotech sector includes Scripps Florida and the Max Planck Florida Institute for Neuroscience in Jupiter, about 200 biotech companies, hospitals, and educational programs including Scripps, Max Planck and Florida Atlantic University’s School of Medicine.
Now that Florida’s economy has essentially recovered from the recession, Smallridge said it’s time for economic officials to make a bigger play for science-related businesses as well as figure how to keep spin-off companies from the institutes in the area.